Immediate Impact

11 by Nobel laureates 10 from Science/Nature 105 standout
Sub-graph 1 of 14

Citing Papers

Prostate cancer
2021 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
59 intermediate papers

Works of A Płużańska being referenced

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
2004 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
A Płużańska 6183 8129 2864 3165 65 11.4k
David Olmos 4020 6034 3095 3168 231 10.0k
Ross A. Okimoto 7168 8004 2659 4847 33 11.9k
Paul N. Mainwaring 2683 6748 2360 2325 142 9.0k
I. Bodrogi 3498 6343 2896 4241 77 10.2k
Carsten Goessl 6062 4332 1982 2982 112 9.4k
Katsuhiko Naoki 6146 7412 2705 4963 124 11.4k
U. Gatzemeier 10488 12028 1746 3552 184 15.9k
Hidefumi Sasaki 6305 7199 2657 4943 143 11.7k
Isan Chen 3565 6901 3054 4715 41 8.9k
Steven D. Averbuch 7926 7370 1561 2824 57 10.9k

All Works

Loading papers...

Rankless by CCL
2026